on EUROAPI (isin : FR0014008VX5)
EUROAPI secures financing for its FOCUS-27 plan
EUROAPI has finalized the financing of its FOCUS-27 strategic plan with several financial initiatives. The company has refinanced a €451 million revolving credit facility, extending its maturity to February 2029. This refinancing, bearing interest indexed to EURIBOR, includes clauses on the leverage ratio and liquidity.
Sanofi has subscribed to a €200 million super-subordinated hybrid bond to support the FOCUS-27 plan, providing EUROAPI with increased financial flexibility. The bond carries a coupon of 8.113% until 2029.
A €54 million agreement with Sanofi will allow for capacity reservations for five products, improving revenues and performance. Amendments to the manufacturing contract are planned, including guaranteed volumes for Sevelamer.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EUROAPI news